Drug profile · INN
mecasermin rinfabate
IPLEX
mecasermin rinfabate (IPLEX) is a insulin-like growth factor i receptor agonist.
EMA: application withdrawn
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — mecasermin rinfabate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
mecasermin rinfabate (IPLEX) is a insulin-like growth factor i receptor agonist.
Key facts
INN mecasermin rinfabate
Brand IPLEX
Mechanism Insulin-like growth factor I receptor agonist
Target Insulin-like growth factor 1 receptor
Mechanism of action
Insulin-like growth factor I receptor agonist
Primary target: Insulin-like growth factor 1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mecasermin rinfabate?
mecasermin rinfabate (IPLEX) is a insulin-like growth factor i receptor agonist.
What is the brand name for mecasermin rinfabate?
IPLEX is a marketed brand name for mecasermin rinfabate. Check FDA Drugs@FDA for the current US label holder and prescribing information.